Oppenheimer Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.82M Sell
101,011
-869
-0.9% -$75.9K 0.1% 227
2025
Q1
$6.96M Buy
101,880
+10,094
+11% +$689K 0.09% 255
2024
Q4
$7.14M Buy
91,786
+11,871
+15% +$923K 0.09% 249
2024
Q3
$5.36M Sell
79,915
-53,993
-40% -$3.62M 0.06% 308
2024
Q2
$15.2M Buy
133,908
+17,443
+15% +$1.98M 0.19% 124
2024
Q1
$16.2M Sell
116,465
-5,811
-5% -$806K 0.24% 99
2023
Q4
$15.2M Buy
122,276
+33,580
+38% +$4.17M 0.21% 112
2023
Q3
$8.28M Sell
88,696
-1,907
-2% -$178K 0.13% 193
2023
Q2
$11.6M Sell
90,603
-839
-0.9% -$108K 0.17% 143
2023
Q1
$10.6M Sell
91,442
-3,430
-4% -$398K 0.16% 156
2022
Q4
$10.7M Sell
94,872
-2,139
-2% -$242K 0.17% 158
2022
Q3
$7.81M Sell
97,011
-1,725
-2% -$139K 0.14% 185
2022
Q2
$7.36M Buy
98,736
+804
+0.8% +$59.9K 0.12% 202
2022
Q1
$12.5M Buy
97,932
+1,012
+1% +$129K 0.18% 138
2021
Q4
$13M Buy
96,920
+2,228
+2% +$299K 0.17% 140
2021
Q3
$12.9M Buy
94,692
+2,076
+2% +$284K 0.18% 131
2021
Q2
$9.89M Buy
92,616
+15,064
+19% +$1.61M 0.14% 174
2021
Q1
$6.97M Buy
77,552
+2,408
+3% +$216K 0.11% 218
2020
Q4
$6.95M Buy
75,144
+844
+1% +$78K 0.12% 206
2020
Q3
$7.66M Buy
74,300
+2,460
+3% +$254K 0.15% 166
2020
Q2
$7.28M Buy
71,840
+600
+0.8% +$60.8K 0.15% 165
2020
Q1
$4.8M Buy
71,240
+528
+0.7% +$35.5K 0.12% 203
2019
Q4
$3.87M Buy
70,712
+1,404
+2% +$76.8K 0.08% 270
2019
Q3
$2.59M Buy
69,308
+1,776
+3% +$66.2K 0.06% 339
2019
Q2
$2.53M Sell
67,532
-932
-1% -$34.9K 0.06% 344
2019
Q1
$2.04M Buy
68,464
+68,064
+17,016% +$2.03M 0.05% 398
2018
Q4
$12K Buy
+400
New +$12K ﹤0.01% 1499
2018
Q1
Sell
-21,636
Closed -$265K 1139
2017
Q4
$265K Hold
21,636
0.01% 968
2017
Q3
$265K Sell
21,636
-76,740
-78% -$940K 0.01% 972
2017
Q2
$1.8M Sell
98,376
-580
-0.6% -$10.6K 0.05% 388
2017
Q1
$2.1M Buy
+98,956
New +$2.1M 0.06% 341